Larvol Delta - Arch-Biopartners-Announces-Metablok-Achieves-Primary-Endpoints-of-Safety-and-Tolerability-in-Phase-I-Trial

MetaBlok (lsalt peptide) - Arch Biopartners

http://www.globenewswire.com/news-release/2019/12/18/1962270/0/en/Arch-Biopartners-Announces-Metablok-Achieves-Primary-Endpoints-of-Safety-and-Tolerability-in-Phase-I-Trial.html

Dec 18, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev